arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

AIBOTICS, INC.

AIBT
Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
9 Visible periods
16 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Bullish
auto_awesome

Analytical Summary

AIBOTICS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC 46.6%
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

9-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.18K
Net Income Profit after all expenses
$-2.22M
↓ -19.9%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
97
Financial Health
32
Cash Quality
29

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters